- President
of ETST’s partner for the manufacturing of Hygee attended fair with Quebec
delegation
- Launch
of Hygee, which tests women for sexually transmitted infections, is
expected in first half of this year
- ETST
recently launched an international marketing campaign for the device
Earth Science Tech Inc. (OTCQB: ETST), a biotech company
that markets and develops hemp cannabinoid products, plans to introduce its
Hygee medical testing kit in the first half of this year. As part of that
strategy, the company showed Hygee at Arab Health 2019, the largest annual
medical trade fair in the Middle East and North Africa (“MENA”) region (http://ibn.fm/KMW9t).
ETST has formed a strategic partnership for Hygee’s
manufacture with Dermagate, a company that specializes in the production of
dermatology and wound-care products. Gaétan Houle, president of Dermagate,
represented ETST at Arab Health 2019 and was accompanied by an eight-company
delegation organized by the Quebec Minister of the Economy and Innovation.
Houle was also scheduled to attend a reception at the Canadian Consulate and
meet with other Canadian trade ministers based in MENA countries.
Hygee is a medical self-sampling kit designed for women to
use in the detection of STIs, starting with chlamydia. Dr. Michel Aubé, ETST’s
CEO and chief science officer, said in a news release that the company’s goal
at the show was to make key business contacts and connect to the MENA region’s
health care industry and market.
In a news release, Houle said, “As previously announced,
Hygee is on its way to being certified ISO-13485, and soon after, it will be
licensed by the U.S. FDA and Health Canada. Moreover, ETST will apply for
licensing Hygee in at least five other countries. This is notable, as many of
North America’s largest medical device companies will attend Arab Health 2019,
as will manufacturers and distributors from around the world.” An estimated
4,000 companies from 66 countries were scheduled to attend the fair, showing
products and services to more than 84,000 visitors and nearly 6,000
dignitaries.
Based in Doral, Florida, ETST produces and sells CBD
products, as well as dietary supplements for the pharmaceutical and
nutraceutical fields. The company is focused on the cannabidiol, pharmaceutical
and nutraceutical sectors, as well as the development, through subsidiaries, of
medical devices and research. ETST’s goal is to become a world leader in the
CBD space.
ETST holds several wholly owned subsidiaries. Cannabis
Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures
and distributes in the recreational sector. Earth Science Foundation Inc. is
becoming a nonprofit and accepts grants and donations to conduct studies. Earth
Science Pharmaceutical develops medical diagnostic tools and vaccines, while
Canna Inno Laboratories Inc. provides ETST with access to government grants.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
